AKT1 and colorectal carcinoma: Further, the decreased expression of MMP‐2, MMP‐9 and phosphorylated Akt in CRC cells with RBM24 overexpressing could be reversed by exposure to the PTEN specific inhibitor SF1670 (Figure 4F).